Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.

Aranow C, Cush J, Bolster MB, Striebich CC, Dall'era M, Mackay M, Olech E, Frech T, Box J, Keating R, Wasko MC, St Clair W, Kivitz A, Huang W, Ricketts P, Welch B, Callahan S, Spychala M, Boyle K, York K, Keyes-Elstein L, Goldmuntz E, Diamond B, Davidson A.

Rheumatology (Oxford). 2019 Oct 18. pii: kez471. doi: 10.1093/rheumatology/kez471. [Epub ahead of print]

PMID:
31628482
2.

Functional analysis of novel RUNX2 mutations identified in patients with cleidocranial dysplasia.

Hordyjewska-Kowalczyk E, Sowińska-Seidler A, Olech EM, Socha M, Glazar R, Kruczek A, Latos-Bieleńska A, Tylzanowski P, Jamsheer A.

Clin Genet. 2019 Nov;96(5):429-438. doi: 10.1111/cge.13610. Epub 2019 Jul 31.

PMID:
31347140
3.

Phenotypic description of two adult brothers presenting with mild form of Smith-Lemli-Opitz syndrome.

Olech EM, Matuszewska K, Piechota M, Latos-Bieleńska A, Jamsheer A.

Clin Dysmorphol. 2019 Jul;28(3):154-156. doi: 10.1097/MCD.0000000000000276. No abstract available.

PMID:
30925529
4.

Correction to: Novel 1q22-q23.1 duplication in a patient with lambdoid and metopic craniosynostosis, muscular hypotonia, and psychomotor retardation.

Sowińska-Seidler A, Olech EM, Socha M, Larysz D, Jamsheer A.

J Appl Genet. 2018 Nov;59(4):525. doi: 10.1007/s13353-018-0460-7.

5.

Novel 1q22-q23.1 duplication in a patient with lambdoid and metopic craniosynostosis, muscular hypotonia, and psychomotor retardation.

Sowińska-Seidler A, Olech EM, Socha M, Larysz D, Jamsheer A.

J Appl Genet. 2018 Aug;59(3):281-289. doi: 10.1007/s13353-018-0447-4. Epub 2018 May 29. Erratum in: J Appl Genet. 2018 Nov;59(4):525.

6.

Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.

Kivitz A, Olech E, Borofsky MA, Zazueta B, Navarro-Sarabia F, Radominski SC, Merrill JT, Pacheco-Tena C, Pei J, Nasmyth-Miller C, Pope JE.

J Rheumatol. 2018 Apr;45(4):456-464. doi: 10.3899/jrheum.161539. Epub 2017 Dec 15.

7.

Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Babary H, Liu X, Ayatollahi Y, Chen XP, Doo L, Uppaluru LK, Kwak MK, Kulaga C, Modjinou D, Olech E, Yoo JW.

Int J Rheum Dis. 2018 Jan;21(1):84-92. doi: 10.1111/1756-185X.13159. Epub 2017 Sep 8. Review.

PMID:
28884965
8.

Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study.

Kivitz A, Wallace T, Olech E, Borofsky M, Devenport J, Pei J, Michalska M.

Rheumatol Ther. 2016 Dec;3(2):291-304. Epub 2016 Sep 24.

9.

Identification of a molecular defect in a stillborn fetus with perinatal lethal hypophosphatasia using a disease-associated genome sequencing approach.

Olech EM, Zemojtel T, Sowińska-Seidler A, Mundlos S, Robinson PN, Karczewski M, Jamsheer A.

Pol J Pathol. 2016 Mar;67(1):78-83.

10.

Exome sequencing reveals two novel compound heterozygous XYLT1 mutations in a Polish patient with Desbuquois dysplasia type 2 and growth hormone deficiency.

Jamsheer A, Olech EM, Kozłowski K, Niedziela M, Sowińska-Seidler A, Obara-Moszyńska M, Latos-Bieleńska A, Karczewski M, Zemojtel T.

J Hum Genet. 2016 Jul;61(7):577-83. doi: 10.1038/jhg.2016.30. Epub 2016 Mar 31.

PMID:
27030147
11.

Development of biosimilars.

Al-Sabbagh A, Olech E, McClellan JE, Kirchhoff CF.

Semin Arthritis Rheum. 2016 Apr;45(5 Suppl):S11-8. doi: 10.1016/j.semarthrit.2016.01.002. Epub 2016 Jan 21. Review.

PMID:
26947440
12.

Biosimilars: Rationale and current regulatory landscape.

Olech E.

Semin Arthritis Rheum. 2016 Apr;45(5 Suppl):S1-10. doi: 10.1016/j.semarthrit.2016.01.001. Epub 2016 Jan 21. Review.

PMID:
26947438
13.

Variable expressivity of the phenotype in two families with brachydactyly type E, craniofacial dysmorphism, short stature and delayed bone age caused by novel heterozygous mutations in the PTHLH gene.

Jamsheer A, Sowińska-Seidler A, Olech EM, Socha M, Kozłowski K, Pyrkosz A, Trzeciak T, Materna-Kiryluk A, Latos-Bieleńska A.

J Hum Genet. 2016 May;61(5):457-61. doi: 10.1038/jhg.2015.172. Epub 2016 Jan 14.

PMID:
26763883
14.

Proceedings from The 8th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) Conference.

Troum OM, Pimienta OL, Olech E, Østergaard M, Thiele R, Seraphine JL, Bruyn GA, Peterfy C.

Semin Arthritis Rheum. 2016 Jun;45(6):e17-23. doi: 10.1016/j.semarthrit.2015.09.007. Epub 2015 Oct 9.

PMID:
26614546
15.

Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients.

Li X, Golubovsky J, Hui-Yuen J, Shah U, Olech E, Lomeo R, Singh V, Busch H, Strandberg MJ, Strandberg K, Horowitz L, Askanase A.

Version 2. F1000Res. 2015 Oct 23 [revised 2016 Jan 1];4:1103. doi: 10.12688/f1000research.7192.2. eCollection 2015.

16.

Hyperosmia, ectrodactyly, mild intellectual disability, and other defects in a male patient with an X-linked partial microduplication and overexpression of the KAL1 gene.

Sowińska-Seidler A, Piwecka M, Olech E, Socha M, Latos-Bieleńska A, Jamsheer A.

J Appl Genet. 2015 May;56(2):177-84. doi: 10.1007/s13353-014-0252-7. Epub 2014 Oct 23.

17.

Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.

Kivitz A, Olech E, Borofsky M, Zazueta BM, Navarro-Sarabia F, Radominski SC, Merrill JT, Rowell L, Nasmyth-Miller C, Bao M, Wright S, Pope JE.

Arthritis Care Res (Hoboken). 2014 Nov;66(11):1653-61. doi: 10.1002/acr.22384.

18.

The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy.

Conaghan PG, Peterfy C, Olech E, Kaine J, Ridley D, Dicarlo J, Friedman J, Devenport J, Troum O.

Ann Rheum Dis. 2014 May;73(5):810-6. doi: 10.1136/annrheumdis-2013-204762. Epub 2014 Feb 13.

19.

Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.

Emery P, Rigby W, Tak PP, Dörner T, Olech E, Martin C, Millar L, Travers H, Fisheleva E.

PLoS One. 2014 Feb 3;9(2):e87379. doi: 10.1371/journal.pone.0087379. eCollection 2014.

20.

Emotional modulation of pain and spinal nociception in fibromyalgia.

Rhudy JL, DelVentura JL, Terry EL, Bartley EJ, Olech E, Palit S, Kerr KL.

Pain. 2013 Jul;154(7):1045-56. doi: 10.1016/j.pain.2013.03.025. Epub 2013 Mar 19.

21.

Safety of rituximab in combination with other biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: an open-label study.

Rigby WF, Mease PJ, Olech E, Ashby M, Tole S.

J Rheumatol. 2013 May;40(5):599-604. doi: 10.3899/jrheum.120924. Epub 2013 Apr 1.

22.

Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932).

Peterfy CG, Olech E, DiCarlo JC, Merrill JT, Countryman PJ, Gaylis NB.

Arthritis Res Ther. 2013 Mar 20;15(2):R44. doi: 10.1186/ar4202.

23.

Proceedings from the 5th Annual International Society for Musculoskeletal Imaging in Rheumatology Annual Conference.

Conaghan PG, Ostergaard M, D'Agostino MA, Gaylis N, Arnold W, Olech E, Wells A, Peterfy C, Seraphine JL, Troum O.

Semin Arthritis Rheum. 2013 Feb;42(4):433-46. doi: 10.1016/j.semarthrit.2012.10.003.

PMID:
23415135
24.

Magnetic resonance imaging applications in early rheumatoid arthritis diagnosis and management.

Troum OM, Pimienta O, Olech E.

Rheum Dis Clin North Am. 2012 May;38(2):277-97. doi: 10.1016/j.rdc.2012.04.001. Epub 2012 May 25. Review.

PMID:
22819084
25.

Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI.

Peterfy CG, DiCarlo JC, Olech E, Bagnard MA, Gabriele A, Gaylis N.

Arthritis Res Ther. 2012 May 30;14(3):R131. doi: 10.1186/ar3861.

26.

Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial.

Stohl W, Gomez-Reino J, Olech E, Dudler J, Fleischmann RM, Zerbini CA, Ashrafzadeh A, Grzeschik S, Bieraugel R, Green J, Francom S, Dummer W.

Ann Rheum Dis. 2012 Aug;71(8):1289-96. doi: 10.1136/annrheumdis-2011-200706. Epub 2012 Feb 2.

27.

Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience.

Peterfy CG, Countryman P, Gabriele A, Shaw T, Anisfeld A, Tsuji W, Olech E, Gaylis NB, Conaghan PG, Strand V, Dicarlo J.

J Rheumatol. 2011 Sep;38(9):2023-30. doi: 10.3899/jrheum.110418.

PMID:
21885511
28.

Alveolar osteitis: a comprehensive review of concepts and controversies.

Kolokythas A, Olech E, Miloro M.

Int J Dent. 2010;2010:249073. doi: 10.1155/2010/249073. Epub 2010 Jun 24.

29.
30.

MRI in rheumatoid arthritis clinical trials: expensive imaging techniques may ultimately save money.

Olech E.

Expert Rev Clin Pharmacol. 2009 Sep;2(5):443-7. doi: 10.1586/ecp.09.34. No abstract available.

PMID:
22112220
31.

Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes.

Gladd DA, Olech E.

Curr Rheumatol Rep. 2009 Feb;11(1):43-51. Review.

PMID:
19171111
32.

Mycophenolate mofetil for lupus nephritis.

Olech E, Merrill JT.

Expert Rev Clin Immunol. 2008 May;4(3):313-9. doi: 10.1586/1744666X.4.3.313.

PMID:
20476921
33.

Using extremity magnetic resonance imaging to assess and monitor early rheumatoid arthritis: the optimal joint combination to be scanned in clinical practice.

Olech E, Freeston JE, Conaghan PG, Hensor EM, Emery P, Yocum D.

J Rheumatol. 2008 Apr;35(4):580-3. Epub 2008 Mar 1.

PMID:
18322995
34.

A modification of the Omeract RA MRI score for erosions for use with an extremity MRI system with reduced field of view.

Freeston JE, Olech E, Yocum D, Hensor EM, Emery P, Conaghan PG.

Ann Rheum Dis. 2007 Dec;66(12):1669-71. Epub 2007 Jul 6.

35.

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study.

Furst DE, Gaylis N, Bray V, Olech E, Yocum D, Ritter J, Weisman M, Wallace DJ, Crues J, Khanna D, Eckel G, Yeilding N, Callegari P, Visvanathan S, Rojas J, Hegedus R, George L, Mamun K, Gilmer K, Troum O.

Ann Rheum Dis. 2007 Jul;66(7):893-9. Epub 2007 Apr 5.

36.

Response: office-based low-field extremity magnetic resonance imaging: is the glass half empty or half full?

Yocum DE, Conaghan PG, Olech E, Peterfy CG.

Arthritis Rheum. 2006 Apr;54(4):1048-50. No abstract available.

37.

The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis.

Olech E, Merrill JT.

Curr Rheumatol Rep. 2006 Apr;8(2):100-8. Review.

PMID:
16569368
38.

DHEA supplementation: the claims in perspective.

Olech E, Merrill JT.

Cleve Clin J Med. 2005 Nov;72(11):965-6, 968, 970-1 passim. Review.

PMID:
16315437
39.

Lingual mandibular bone vavity concomitant with a dentigerous cyst. A clinical and histologic report.

Alvares O, Olech E, Silverglade LB.

Oral Surg Oral Med Oral Pathol. 1969 Feb;27(2):252-6. No abstract available.

PMID:
5249522
40.

Central mucoepidermoid tumors of the jaws. Review of the literature and case report.

Silverglade LB, Alvares OF, Olech E.

Cancer. 1968 Sep;22(3):650-3. No abstract available.

PMID:
4299781
41.

Ameloblastic odontoma. Report of a case.

Olech E, Alvares O.

Oral Surg Oral Med Oral Pathol. 1967 Apr;23(4):487-92. No abstract available.

PMID:
5227401
42.

Pyrrocaine HCl - A Preliminary Clinical Study of Its Uses in Oral Surgery.

Olech E.

J Am Dent Soc Anesthesiol. 1963 Oct;10(8):224-9. No abstract available.

43.

RANULA.

OLECH E.

Oral Surg Oral Med Oral Pathol. 1963 Oct;16:1169-73. No abstract available.

PMID:
14079985
44.

MIXED TUMOR OF THE LIP. REPORT OF A CASE.

OLECH E.

Oral Surg Oral Med Oral Pathol. 1963 Sep;16:1033-8. No abstract available.

PMID:
14061134
45.

COMPLEX COMPOSITE ODONTOMA. A CLINICAL AND HISTOLOGIC REPORT.

OLECH E.

Oral Surg Oral Med Oral Pathol. 1963 Aug;16:960-4. No abstract available.

PMID:
14049124
46.

Hemangioma of the cheek involving the opening of Stensen's duct treated by injection of a sclerosing solution.

OLECH E.

Oral Surg Oral Med Oral Pathol. 1963 Jun;16:641-4. No abstract available.

PMID:
13939942
47.

Lingual mandibular bone cavity.

OLECH E, ARORA BK.

Oral Surg Oral Med Oral Pathol. 1961 Nov;14:1360-6. No abstract available.

PMID:
14481720
48.

Median mandibular cysts; a clinical and histologic report of two cases.

OLECH E.

Oral Surg Oral Med Oral Pathol. 1957 Jan;10(1):69-74. No abstract available.

PMID:
13400482
49.

Replanted upper central incisor; a case report.

OLECH E.

Oral Surg Oral Med Oral Pathol. 1956 Jan;9(1):106-9. No abstract available.

PMID:
13297371
50.

The terminology of the so-called traumatic bone cyst.

OLECH E, SICHER H, WEINMANN JP.

Oral Surg Oral Med Oral Pathol. 1955 Sep;8(9):962. No abstract available.

PMID:
13254120

Supplemental Content

Support Center